Latest News
Breaking news and real-time updates from the ASX small-cap market
Lefroy Exploration Enhances High-Grade Gold Growth Case for Mt Martin Deposit
Lefroy Exploration extends Mt Martin's high-grade gold project beyond 460,000oz MRE with 8m at 3.93g/t and 6m at 5.48g/t; scoping study due Sept quarter.
Clarity Pharmaceuticals Adds Two Complete Responses to SECuRE Trial Data
Clarity Pharma reports two new complete responses at 8GBq in SECuRE trial, boosting radiographic disease control to seven; PSA declines strong.
Adisyn Achieves Major Graphene Scale-Up Milestone on 200mm Semiconductor Wafer
Adisyn scales graphene deposition to a full 200mm wafer below 300°C over 314 cm², ahead of schedule and validating a scalable platform.
BlinkLab Reports Positive ADHD Assessment Results from European Dx2 Diagnostic Platform Study
BlinkLab reports ADHD Dx2 results: 82% sensitivity, 83% specificity in European study, signaling new smartphone-based diagnostic tool.
Utah Backs Anson Resources’ Green River Lithium Development with Proposed US$357.7m Incentive
Anson Resources climbs on Utah's US$357.7m incentives for Anson's Green River lithium project; boosts after-tax cash flow and IRR, with final terms due Sept.
True North Copper Maps Low-Capital Wynberg Gold-Copper Development Pathways
True North Copper unveils three low-capital Wynberg pathways, with up to $87m pre-tax cash flow and $23m-$38m funding (ASX:TNC).
Forrestania Resources Lifts MRE at Historical British Hill Gold Deposit by 131%
Forrestania Resources lifts British Hill MRE 131% to 2.62 Mt at 1.50 g/t for ~126 koz; drilling continues with three rigs.
Experience Co Lifts Revenue as Adventure Experiences Offset Skydiving Weakness
Experience Co lifts Q4 revenue 1% to $29.4m as Adventure Experiences offset Skydiving weakness, but EBITDA falls 31% to $2.0m on weather and fuel costs.
Entropy Neurodynamics Gains Ethics Approval for Eight-Indication TRP-8803 Trial
Entropy Neurodynamics gains ethics approval for Phase 1b/2a eight-indication TRP-8803 basket trial; first dosing this quarter.
Vmoto More than Doubles First-Half Sales on Continued Order Book Strength
Vmoto H1 EV sales up 140% to 12,713; Q2 6,020 (+156%), on track to 2026 guidance as MotoGP deal and Asia expansion accelerate.
Metallium Signs FJH Commercial Monetisation Deal with Environmental Clean Technologies
Metallium seals 12-month monetisation deal with ECT for FJH MXene production; upfront US$500,000, up to US$1.4m cash, 20m ECT options, exclusive MXene license.
Control Bionics Secures FDA Registration for NeuroStrip Wearable Platform
Control Bionics wins FDA registration for NeuroStrip, boosting regulatory credibility and accelerating growth in Performance, Rehab, and Research.